CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 17, 16:00
CNBX Pharmaceuticals Cash from Operations (Quarterly) : -0.0477M for May 31, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.0477M |
| February 28, 2026 | -0.0305M |
| November 30, 2025 | -0.0474M |
| August 31, 2025 | -0.0285M |
| May 31, 2025 | -0.052M |
| February 28, 2025 | -0.0517M |
| November 30, 2024 | -0.0391M |
| August 31, 2024 | -0.0482M |
| May 31, 2024 | 0.0002M |
| February 29, 2024 | -0.1244M |
| November 30, 2023 | -0.0718M |
| August 31, 2023 | 0.0205M |
| May 31, 2023 | -0.0186M |
| February 28, 2023 | -0.0185M |
| November 30, 2022 | -0.0959M |
| August 31, 2022 | -0.1495M |
| May 31, 2022 | -0.3754M |
| February 28, 2022 | -0.5548M |
| November 30, 2021 | -0.5995M |
| August 31, 2021 | -0.5818M |
| May 31, 2021 | -0.6161M |
| February 28, 2021 | -0.7023M |
| November 30, 2020 | -0.5926M |
| August 31, 2020 | -0.714M |
| May 31, 2020 | -0.5757M |
| Date | Value |
|---|---|
| February 29, 2020 | -0.7236M |
| November 30, 2019 | -0.7617M |
| August 31, 2019 | -0.8687M |
| May 31, 2019 | -0.8186M |
| February 28, 2019 | -0.7393M |
| November 30, 2018 | -0.6671M |
| August 31, 2018 | -0.6215M |
| May 31, 2018 | -0.4656M |
| February 28, 2018 | -0.4346M |
| November 30, 2017 | -0.453M |
| August 31, 2017 | -0.3435M |
| May 31, 2017 | -0.2054M |
| February 28, 2017 | -0.1677M |
| November 30, 2016 | -0.147M |
| August 31, 2016 | -0.0694M |
| May 31, 2016 | 0.0111M |
| February 29, 2016 | -0.0262M |
| November 30, 2015 | -0.0357M |
| August 31, 2015 | -0.028M |
| May 31, 2015 | 0.0156M |
| February 28, 2015 | -0.0571M |
| November 30, 2014 | -0.1096M |
| August 31, 2014 | |
| May 31, 2014 | -0.0331M |
| February 28, 2014 | -0.0405M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -2.536M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -48.30M |
| Fulcrum Therapeutics, Inc. | -16.04M |
| Definium Therapeutics, Inc. | -52.33M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.045M |
| Free Cash Flow | -0.1542M |
| Free Cash Flow to Equity (Quarterly) | -0.0495M |
| Free Cash Flow to Firm (Quarterly) | -0.0477M |
| Free Cash Flow Yield | -174.4% |